W hereas apathy is increasingly recognised as a frequent

Size: px
Start display at page:

Download "W hereas apathy is increasingly recognised as a frequent"

Transcription

1 1070 PAPER On the overlap between apathy and depression in dementia S E Starkstein, L Ingram, M L Garau, R Mizrahi... See end of article for authors affiliations... Correspondence to: Dr Sergio E Starkstein, Fremantle Hospital, Education Building T-7, Fremantle WA 6959, Australia; ses@cyllene. uwa.edu.au Received 26 August 2004 Revised version received 17 October 2004 Accepted 17 November J Neurol Neurosurg Psychiatry 2005;76: doi: /jnnp Background: Whereas apathy is increasingly recognised as a frequent abnormal behaviour in dementia, its overlap with depression remains poorly understood. Aims: To assess the psychometric characteristics of a structured interview for apathy, and to examine the overlap between apathy and depression in dementia. Methods: A total of 150 patients with Alzheimer s disease (AD) underwent a comprehensive psychiatric and cognitive assessment. Results: Twelve per cent of the sample met criteria for both apathy and depression, 7% met criteria for apathy only, and 31% met criteria for depression only. Apathy (but not depression) was significantly associated with more severe cognitive deficits. Apathy and anxiety scores accounted for 65% of the variance of depression scores in dementia, and the diagnosis of apathy had a minor impact on the rating of severity of depression. Conclusions: The Structured Interview for Apathy demonstrated adequate psychometric characteristics. Using a novel structured interview for apathy in AD we demonstrated that whereas the construct of depression primarily consists of symptom clusters of apathy and anxiety, apathy is a behavioural dimension independent of depression. W hereas apathy is increasingly recognised as a frequent behavioural problem in dementia, its nosological position remains unclear. The philosophical meaning of apathy is lack of passion, the latter being an extreme form of emotion. 1 The Stoic philosophers aimed at being free of passions, given that in their conception only a state of true apathy would release the human mind from emotional constraints. The contemporary psychiatric meaning of apathy is obviously different from the Stoic and more akin to the concept of abulia, which is defined as loss, lack or impairment of the power to will or execute what is in mind. 2 Kraepelin defined manic depressive insanity as a state of abnormal volition, emotion, and cognition, and this conception is included in contemporary psychiatric nomenclatures. 3 The modern concepts of apathy and depression both share the predicate of reduced volition (in the etymological sense of acting an intention ), which automatically implies a phenomenological overlap. Depression could still occur in the absence of apathy, provided depressed individuals show mood-congruent emotional changes, whereas apathy could occur in the absence of depression provided the changes in volition do not co-occur with the emotional changes of depression. The frequencies of apathy and depression in dementia were reported to vary widely, and different phenomenological conceptions of these constructs may explain discrepant findings. 45 Another confounding factor is that, to our knowledge, structured instruments to diagnose apathy have not been developed, and apathy has been mostly diagnosed using arbitrary cut off scores on ad hoc severity rating scales. Main aims for the present study were to assess the psychometric characteristics of the newly designed Structured Interview for Apathy, to diagnose apathy in dementia based on standardised criteria, and to examine the phenomenological overlap between apathy and depression. METHOD Patients Alzheimer s disease group The Alzheimer s disease (AD) group consisted of 154 consecutive patients with progressive cognitive decline who visited the dementia clinic at a large tertiary clinic centre in Buenos Aires, Argentina. The patients met the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer s Disease and Related Disorders Association criteria for probable AD. 6 None of the patients had a history of stroke, evidence of focal lesions on a magnetic resonance imaging brain scan (T1 weighted), or a Hachinski ischemic score.4. 6 Psychiatric examination After the methodology of the study had been fully explained, written informed consent was obtained from the patients and their respective caregivers. Four patients declined participation. The evaluation included administration of the Structured Clinical Interview for DSM-IV (SCID), 7 a semi-structured diagnostic interview for assessing signs and symptoms necessary for the major axis I DSM-IV diagnoses; the Mini-Mental State Exam, 8 a global measure of cognitive deficits; the Hamilton Depression Rating Scale, 9 a 17 item interviewer rated scale for rating the severity of symptoms of depression; the Hamilton Anxiety Rating Scale, 10 a 14 item interviewer rated scale for rating the severity of symptoms of anxiety; the Clinical Dementia Rating, 11 a global rating device for dementia stages; and the Irritability and Apathy Scales, 14 item scales for rating the severity of symptoms of irritability and apathy, respectively. 12 Patients with AD were interviewed first. Simultaneously, caregivers, who were blind to the results of these interviews, rated the patients behaviours with the corresponding instruments. Finally, the psychiatrist administered the SCID and the Structured Interview for Apathy (described below) to each patient, with both the patient and the caregiver present. We previously demonstrated the reliability and validity of these instruments in dementia. Diagnosis of apathy We designed the Structured Interview for Apathy to screen for symptoms of apathy as operationalised by Marin 14 and Starkstein et al 13 into clinical diagnostic criteria. The Abbreviations: AD, Alzheimer s disease; CAMDEX, Cambridge Examination for Mental Disorders of the Elderly; MMSE, Mini-Mental State Examination; SCID, Structured Clinical Interview for DSM-IV

2 Apathy and depression in dementia 1071 Structured Interview for Apathy includes questions assessing the domains of lack of motivation relative to the individual s previous level of functioning, lack of effort to perform every day activities, dependency on others to structure activity, lack of interest in learning new things or in new experiences, lack of concern about one s personal problems, unchanging or flat affect, and lack of emotional response to positive or negative personal events. All questions were structured using the SCID format. Each criterion is assessed with two key questions, and additional follow up questions are used to rate the severity of symptoms. Criterion A (lack of motivation relative to the patient s previous level of functioning) is assessed with the following questions: Did you notice a lack of or diminished motivation to perform the activities of daily living? Does it happen most of the day, almost every day?. These questions are followed by specific questions to rate the frequency of the symptom, the approximate date of onset, the pattern of progression, and discrepancies in the information provided by patient and caregiver. All these questions are assessed for all the subsequent positive responses for each of the following items: criterion B1 (lack of effort or energy to perform everyday activities (for example, grooming, work, social life): Did you notice lack of or putting less effort into your everyday activities? If an extra effort is needed do you refrain from doing things? Are you less helpful in household chores? ; criterion B2 (dependency on prompts from others to carry out everyday activities): Do you feel that in order to carry out your daily activities you need that someone indicates or organises your activities? Do you need a push to start doing your daily activities? ; criterion B3 (lack of interest in learning new things, or in new experiences): Do you feel that you have less interest to learn new things? (for example, reading newspapers, books, watching TV)? Do you note less interest to learn about events in your environment, such as family meetings, neighbourhood news? ; criterion B4 (lack of concern about one s personal problems): Are you indifferent or less interested in your personal situation? Are you indifferent to your health condition, working situation, hobbies, or personal care? ; and criterion B5 (unchanging or flat affect, lack of emotional response to positive or negative events): Do you have a flat mood, with little or no fluctuations? Do you feel indifferent in your emotions, neither happy nor sad about positive or negative events in your environment?. Based on answers to these questions, symptoms are scored as either absent, subclinical, or definitely present. Criterion C assesses the extent of social and occupational dysfunction caused by the symptoms of apathy, and criterion D excludes organic causes of behavioural changes other than dementia. Apathy is diagnosed whenever patients had a score of 3 (that is, definitely present ) on criterion A, a score of 3 on at least three B criteria, and a score of 1 (that is, absent) on criteria C and D. Statistical analysis Statistical analysis was carried out with the use of means and standard deviations, two way analysis of variance (ANOVA), and Tukey s post hoc tests. A principal components factor analysis for the Hamilton Depression Rating Scale was carried out using varimax rotation. Frequency distributions were calculated with x 2 and Fisher s exact tests. All p values are two tailed. RESULTS Psychometric characteristics of the structured interview for apathy Test-retest reliability was calculated by a single examiner, who assessed 10 patients (four with and six without an initial diagnosis of apathy), 2 4 weeks apart. Diagnostic agreement between the initial and follow up evaluations was perfect (100%). Inter-rater reliability was assessed in an additional series of 10 patients (three with and seven without apathy), in separate interviews (2 4 weeks apart) carried out by two different examiners blind to each other s diagnosis. There was perfect (100%) diagnostic agreement between examiners. The Structured Interview for Apathy had high internal consistency (Cronbach s a = 0.91), indicating substantial homogeneity among the items. Based on information obtained with the Structured Interview for Apathy, patients meeting diagnostic criteria for apathy (n = 29) had a significantly higher mean (SD) score on the caregiver s rated Apathy Scale than patients without apathy (n = 121): 24.1 (9.1) v 15.5 (8.1), respectively; t = 4.74, df = 148, p, Demographic and clinical findings Twenty nine (19%) of the 150 patients met Marin s diagnostic criteria for apathy. Thirteen (45%) of the 29 patients with apathy also had major depression, five patients (17%) had minor depression, and 11 patients (38%) were not depressed. Among patients without a clinical diagnosis of apathy, 17 (14%) had major depression, 30 (25%) had minor depression, and 74 (61%) had no depression (x 2 = 13.8, df = 2, p,0.001). Patients with apathy had similar age, years of education, and duration of illness to patients without apathy (table 1). To examine different clinical correlates of depression and apathy, we calculated two way ANOVAs using a 262 factorial design, which included patients with apathy and major depression (n = 13), patients with apathy but no depression (n = 11), patients with major depression but no apathy (n = 17), and patients with neither major depression nor apathy (n = 74) (due to the small sample, patients with minor depression (with or without apathy) were excluded from this comparison). A two way ANOVA (depression by apathy) for Mini-Mental State Examination (MMSE) scores (three patients had missing scores) showed a significant effect for apathy (F = 9.36, df = 1,108, p,0.01): patients with apathy (with or without depression) had significantly more severe cognitive deficits than patients without apathy. There was neither a significant effect for depression nor a significant depression by apathy interaction. Phenomenology of apathy and depression in dementia We next examined whether symptoms of apathy may be construed as a specific sub-syndrome within the spectrum of depression in dementia, and to this end we calculated a factor analysis on the 17 item Hamilton Depression Rating Scale. To reduce the number of variables, the items of loss of appetite and weight, and the items of early, middle, and late insomnia were collapsed into single variables of appetite and sleep disturbances, respectively. Two factors were obtained. The first factor loaded (.0.50) on the items of loss of interest, psychomotor retardation, agitation, loss of energy, and loss of appetite/weight (eigenvalue: 4.70, variance: 33%) and was construed as an apathy factor. The second factor loaded on the items of depressed mood, feelings of guilt, suicidal ideation, psychic anxiety, and insomnia (eigenvalue: 1.23, variance: 9%) and was construed as a sadness/anxiety factor. To examine the clinical correlates of each factor, we calculated a stepwise regression analysis with each factor as the dependent variable, and age, years of education, stage of illness, and scores of cognition, anxiety, and apathy as the independent variables (11 patients with missing values had to be excluded from this analysis). Factor 1 (apathy) showed a significant overall correlation (R 2 = 0.45, df = 3,127, p,0.0001), and the variables that accounted for a significant part of the variance were the apathy scores (R 2 = 0.32, p,0.0001), anxiety scores (R 2 = 0.08, p,0.0001) (that is,

3 1072 Starkstein, Ingram, Garau, et al Table 1 Demographic and clinical characteristics of consecutive patients with probable AD who did and did not meet criteria for apathy and depression* Patients with neither apathy nor depression (n = 74) higher scores on the apathy factor were significantly correlated with higher apathy and anxiety scores), and MMSE scores (R 2 = 0.04, p,0.01) (that is, higher scores on the apathy factor were significantly correlated with lower MMSE scores). Factor 2 (sadness/anxiety) showed a significant overall correlation (R 2 = 0.27, df = 3,127, p,0.0001), but only anxiety scores explained a significant part of the variance (R 2 = 0.25, p,0.0001). Overlap of apathy and depression in dementia The question also arises as to whether a diagnosis of apathy may artificially increase depression scores. To address this issue we calculated a two way ANOVA including apathy and major depression diagnoses as the grouping variables, and total scores on the Hamilton Depression Rating Scale as the dependent variable. There was the expected significant effect for depression (F = 85.2, df = 1,108, p,0.0001) and a significant effect for apathy (F = 4.96, df = 1,108, p,0.05), but no significant depression by apathy interaction (F = 0.72, df = 1,108, p = 0.39), demonstrating that the coexistence of apathy and depression does not produce higher depression scores than depression only. Finally, a stepwise regression analysis with Hamilton depression scores as the dependent variable and scores of apathy (caregiver version), anxiety, MMSE, age, and scores on the sad mood item of the SCID (that is, ratings of 1 (no depressed mood), 2 (questionable depressed mood), and 3 (definite depressed mood)) as the independent variables showed a significant overall effect (R 2 = 0.68, F = 79.8, p,0.0001), and the variables that explained a significant part of the variance were anxiety (53%), apathy (13%), and sadness (2%). DISCUSSION We demonstrated the reliability and validity of the Structured Interview for Apathy, and we examined the overlap between the constructs of apathy and depression in dementia. Apathy was present in 19% of patients, and 62% of the patients with apathy were also depressed. On the other hand, only 28% of the patients with depression had comorbid apathy. A factor analysis on the Hamilton Depression Rating Scale demonstrated a factor accounting for 33% of the variance that strongly correlated with scores on the Apathy Scale. Apathy Patients with apathy and without depression (n = 11) Patients with depression and without apathy (n = 47) n (%) n (%) n (%) n (%) Female gender 44 (59) 5 (45) 33 (70) 12 (67) Major depressionà 17 (36) 13 (72) Minor depression 30 (64) 5 (28) Medications received Neuroleptics 3 (4) 2 (18) 6 (13) 5 (28) Antidepressants 5 (7) 2 (18) 6 (13) 6 (33) Anxiolytics 8 (11) 1 (9) 14 (30) 9 (50) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Age (years) 69.2 (10.2) 71.8 (13.8) 71.8 (10.0) 71.6 (8.2) Apathy Scale score Caregiver rating` 12.1 (7.2) 20.3 (10.5) 22.2 (6.2) 30.2 (4.2) Patient rating1 5.8 (7.0) 17.7 (9.6) 16.1 (9.4) 27.9 (7.4) Hamilton Depression Scaleô 5.5 (4.5) 7.6 (3.9) 18.0 (9.2) 22.6 (8.2) Hamilton Anxiety Scale** 5.7 (4.4) 5.7 (4.3) 14.0 (7.6) 19.2 (11.4) MMSE scoreàà 24.2 (5.7) 20.6 (5.3) 23.5 (4.5) 19.0 (2.8) Patients with both apathy and depression (n = 18) *Apathy was diagnosed using the Structured Interview for Apathy and Diagnostic Clinical Criteria for Apathy. Diagnoses of depression were made with the Structured Clinical Interview for DSM-IV (SCID). Significant difference between groups: Àx 2 = 13.8, df = 2, p,0.01; `F = 22.5, df = 3,146, p,0.0001; 1F = 22.1, df = 3,146, p,0.0001; ôf = 40.2, df = 3,146, p,0.0001; **F = 13.2, df = 3,142, p,0.0001; ÀÀF = 4.35, df = 3,143, p,0.01. MMSE, Mini-Mental State Examination. was also diagnosed in a group of patients without syndromal depression, and a diagnosis of apathy had a minor impact on the rating of severity of depression in dementia. Finally, apathy, but not depression, was significantly associated with more severe cognitive deficits. Before further comments, several limitations of our study should be pointed out. First, we do not have follow up data on our sample, and the temporal consistency of the diagnosis of apathy will have to be examined in future studies. Second, we have no pathological confirmation of our clinical diagnosis of probable AD. However, the NINCDS-ADRDA criteria have been demonstrated to have high sensitivity and specificity for the diagnosis of probable AD. Whereas the negative impact of depression and apathy on the quality of life of patients with dementia and their respective caregivers has been consistently replicated, consensus as to how to diagnose these mood and behavioural changes has only recently emerged Several studies demonstrated the validity of symptoms of depression in AD, and specific diagnostic criteria have been proposed. 21 The present study demonstrated that anxiety and apathy explain 65% of the variance with depression scores, whereas sadness only accounted for 2% of the variance. This finding suggests that, at least in dementia, depression may primarily result from a combination of symptoms of anxiety and apathy. On the other hand, the nosological position of apathy remains obscure, with some studies suggesting that apathy and depression are independent constructs, and other studies showing a significant overlap between apathy and depression. Frisoni and colleagues 22 and Aalten and colleagues 23 calculated a factor analysis on the Neuropsychiatric Inventory scores from AD patients and found that both apathy and depressed mood loaded on a single factor. On the other hand, using the same instrument and analytic technique, Fuh and coworkers 24 found that apathy and depression loaded on two independent factors. Strauss and Sperry 16 examined a series of 100 AD patients with an informant based assessment of apathy, and found no significant association between apathy and depression. de Jonghe and coworkers 25 assessed a series of 281 patients using the Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) and found that apathy and depression loaded on two independent factors. Our study

4 Apathy and depression in dementia 1073 addressed this issue using structured psychiatric interviews, standardised diagnostic criteria, and specific rating scales for both apathy and depression. A factor analysis of the Hamilton Depression Rating Scale produced two factors: the first included psychomotor retardation, loss of interest, poor energy, agitation, and poor appetite, and was construed as an apathy factor. The second factor included sad mood, guilt and suicidal ideation, anxiety, and insomnia, and was construed as a sadness/anxiety factor. We found significant positive correlations between the apathy factor and scores on the Apathy Scale, and between the sadness/anxiety factor and scores of anxiety and apathy. This finding is similar to the report by Marin et al 26 of a significant positive correlation between apathy scores and the Hamilton Depression Scale cluster of apathy symptoms (loss of interest, psychomotor retardation, lack of energy, and loss of insight). The frequency of apathy in our patients with major depression was significantly higher than in patients with minor depression (43% v 14%, x 2 = 6.81, df = 1, p,0.01), suggesting different mechanisms for these disorders in AD. Alternatively, major depression with apathy could be a more severe type of depression. In a previous study on a different sample of patients with AD, we found that depressive symptoms started before the onset of cognitive deficits in about half of the patients with major depression, and the frequency of major depression was similar across the stages of AD. 27 On the other hand, depressive symptoms started after the onset of cognitive deficits in 90% of patients with dysthymia, the frequency of dysthymia was significantly higher in the early stages of dementia, and dysthymia was associated with a better awareness of functional impairments as compared to patients with either major or no depression. Based on these findings we suggested that dysthymia in AD could be a negative emotional reaction to the progressive cognitive decline, whereas major depression in AD could be more strongly related to biological factors. We also found a significant correlation between more severe apathy (but not depression) and more severe cognitive deficits. Similar associations between apathy and cognitive deficits have been reported in healthy elderly individuals and in patients with AD. The frequency of apathy in the present study (19%) is lower than in other recent studies (ranging from 44% to 80%), and several methodological differences may explain these discrepancies. Most other studies used broad behavioural symptom inventories, whereas we used a structured interview that was specifically designed to assess apathy in AD. Moreover, whereas most other studies diagnosed apathy based on cut off scores on ad hoc scales, we diagnosed apathy using standardised criteria that have been validated for the diagnosis of apathy in AD. Another important difference is that the mean MMSE score for our sample (23 points) was higher than in previous studies (with mean MMSE scores ranging from 13 to 18 points) Given that the frequency of apathy increases with the severity of dementia, the lower frequency of apathy in the present study may be related to the relatively less severe dementia in our sample as compared to previous studies. In conclusion, we demonstrated the reliability and validity of the Structured Interview for Apathy in AD. We found that most patients with dementia and apathy had concomitant depression, but less than one third of depressed patients had concomitant apathy. Apathy in AD has been consistently associated with relatively more severe cognitive deficits, more severe impairments in activities of daily living, higher levels of burden and distress in caregivers, and increased resource utilisation. 4 The use of specific structured interviews and valid diagnostic criteria to assess and diagnose apathy in AD will improve the identification of more homogeneous behavioural phenotypes and may help to clarify the mechanisms of these disorders. ACKNOWLEDGEMENTS We thank Janus Kremer, MD, Alicia Lischinski, MD, and Gustavo Petracca, MD for their contribution to the study, and Professor Assen Jablensky for his advice.... Authors affiliations S E Starkstein, Raul Carrea Institute of Neurological Research, Buenos Aires, Argentina L Ingram, Fremantle Hospital, Fremantle, Australia M L Garau, Departamento de Neurologia, Hospital Fernandez, Buenos Aires, Argentina R Mizrahi, PET Center for Addiction and Mental Health, Clarke Division, Toronto, Canada This study was partially supported with grants from the University of Western Australia, the Australian Rotary Health Research Fund, the Raine Medical Research Foundation, and the Fremantle Hospital Research Foundation. Competing interests: none declared Ethics approval: the protocol for this study was approved by the institutional Ethics Committee. REFERENCES 1 Inwood B. Ethics and human action in early Stoicism. Oxford: Clarendon Press, Berrios GE. The history of mental symptoms. Cambridge: Cambridge University Press, Kraepelin E. Manic depressive insanity and paranoia. Salem, NH: Ayer, Landes AM, Sperry SD, Strauss ME, et al. Apathy in Alzheimer s disease. JAm Geriatr Soc 2001;49(12): Olin JT, Schneider LS, Katz IR, et al. Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry 2002;10(2): McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer s Disease. Neurology 1984;34(7): Spitzer RL, Williams JB, Gibbon M, et al. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description, Arch Gen Psychiatry 1992;49(8): Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3): Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23: Hamilton MA. The assessment of anxiety state by rating. Br J Med Psychol 1959;32: Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140: Starkstein SE, Migliorelli R, Manes F, et al. The prevalence and clinical correlates of apathy and irritability in Alzheimer s disease. Eur J Neurol 1995;2: Starkstein SE, Petracca G, Chemerinski E, et al. Syndromic validity of apathy in Alzheimer s disease. Am J Psychiatry 2001;158(6): Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991;3(3): Boyle PA, Malloy PF, Salloway S, et al. Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry 2003;11(2): Strauss ME, Sperry SD. An informant-based assessment of apathy in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol 2002;15(3): McPherson S, Fairbanks L, Tiken S, et al. Apathy and executive function in Alzheimer s disease. J Int Neuropsychol Soc 2002;8(3): Robert PH, Clairet S, Benoit M, et al. The apathy inventory: assessment of apathy and awareness in Alzheimer s disease, Parkinson s disease and mild cognitive impairment. Int J Geriatr Psychiatry 2002;17(12): Ready RE, Ott BR, Grace J, et al. Apathy and executive dysfunction in mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry 2003;11(2): Marin RS, Butters MA, Mulsant BH, et al. Apathy and executive function in depressed elderly. J Geriatr Psychiatry Neurol 2003;16(2): Olin JT, Katz IR, Meyers BS, et al. Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. Am J Geriatr Psychiatry 2002;10(2): Frisoni GB, Rozzini L, Gozzetti A, et al. Behavioral syndromes in Alzheimer s disease: description and correlates. Dement Geriatr Cogn Disord 1999;10(2):130 8.

5 1074 Starkstein, Ingram, Garau, et al 23 Aalten P, de Vugt ME, Lousberg R, et al. Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory. Dement Geriatr Cogn Dis 2003;15(2): Fuh JL, Liu CK, Mega MS, et al. Behavioral disorders and caregivers reaction in Taiwanese patients with Alzheimer s disease. Int Psychogeriatr 2001;13(1): de Jonghe JF, Goedhart AW, Ooms ME, et al. Negative symptoms in Alzheimer s disease: a confirmatory factor analysis. Int J Geriatr Psychiatry 2003;18(8): Marin RS, Firinciogullari S, Biedrzycki RC. Group differences in the relationship between apathy and depression. J Nerv Ment Dis 1994;182(4): Migliorelli R, Teson A, Sabe L, et al. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer s disease. Am J Psychiatry 1995;152: Lampe IK, Kahn RS, Heeren TJ. Apathy, anhedonia, and psychomotor retardation in elderly psychiatric patients and healthy elderly individuals. J Geriatr Psychiatry Neurol 2001;14(1): Burns A, Folstein S, Brandt J, et al. Clinical assessment of irritability, aggression, and apathy in Huntington and Alzheimer disease. J Nerv Ment Dis 1990;178(1): Mega MS, Cummings JL, Fiorello T, et al. The spectrum of behavioral changes in Alzheimer s disease. Neurology 1996;46(1): Levy ML, Cummings JL, Fairbanks LA, et al. Apathy is not depression. J Neuropsychiatry Clin Neurosci 1998;10(3): NEUROLOGICAL PICTURE... doi: /jnnp Ventriculitis and hydrocephalus: an unusual presentation of toxoplasmosis in an adult with human immunodeficiency virus A 33 year old African man presented with a history of fever, confusion, and headache. An magnetic resonance imaging (MRI) scan revealed hydrocephalus, marked enhancement within the ventricular walls, and extensive confluent T2-weighted/fluid attenuated inversion recovery (FLAIR), high signal around the 3 rd and lateral ventricles, as well as within the splenium of the corpus callosum. Bilateral extra-ventricular drains were inserted. Cerebrospinal fluid (CSF) examination revealed: 28/mm 3 lymphocytes, protein 2557 mg/l, glucose 1.8 mmol/l (serum 6.3 mmol/l), no organisms, and polymerase chain reaction (PCR) negative for tuberculosis (TB), cytomegalovirus (CMV), herpes simplex virus (HSV), and JC virus, but positive for Epstein-Barr virus (EBV). An human immunodeficiency virus (HIV)-1 enzyme-linked immunosorbent assay (ELISA) was positive with a CD4 count of 158/mm 3. Serum CMV IgG and Toxoplasma IgG were positive consistent with previous exposure. Treatment was commenced with anti-tuberculous medication, Aciclovir, and Ganciclovir. Despite this, he deteriorated and died a few days later. Post-mortem examination revealed extensive necrotising toxoplasmosis along the ventricular walls. The radiological differential diagnosis of ventriculitis in HIV infection is usually that of TB, CMV, or lymphoma. 1 In the context of HIV disease, lesions in the corpus callosum are most often seen in lymphoma and rarely in toxoplasmosis. 2 Positive EBV PCR is also thought to be both highly sensitive and specific for primary central nervous system (CNS) lymphoma. 3 Cerebral toxoplasmosis in the immunocompromised characteristically presents with mass lesions and although hydrocephalus is a common manifestation in congenital toxoplasmosis, it is rarely seen in adults. 4 Our case stresses the importance that in HIV disease, neuroradiological and laboratory investigations can be grossly misleading, and that a trial of empirical anti-toxoplasmosis treatment should be considered for any CNS lesion in a deteriorating patient. T de Silva M Raychaudhuri M Poulton The Caldecot Centre, King s Healthcare NHS Trust, London, UK A Achar Department of Neurology, King s College Hospital T Hampton Department of Neuroradiology, King s College Hospital Correspondence to: Dr M Poulton, Consultant in HIV Medicine, The Caldecot Centre, King s Healthcare NHS Trust, Caldecot Road, London SE5 9RS, UK; Mary.Poulton@kingsch.nhs.uk References 1 Guerini H, Helie O, Leveque C, et al. Diagnosis of periventricular ependymal enhancement in MRI in adults. J Neuroradiol 2003;30: Lee HJ, Williams R, Kalnin A, et al. Toxoplasmosis of the Corpus Callosum: Another Butterfly. Am J Roetgenol 1996;166: Antinori A, Ammassari A, De Luca A, et al. Diagnosis of AIDS-related focal brain lesions: A decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. American Academy of Neurology 1997;48: Lorberboym M, Wallach F, Estok L, et al. Rapid Differential Diagnosis of Cerebral Toxoplasmosis and Primary Central Nervous System Lymphoma by Thallium-201 SPECT. Journal of Nuclear Medicine 1996;37:

Anosognosia, or loss of insight into one s cognitive

Anosognosia, or loss of insight into one s cognitive REGULAR ARTICLES Anosognosia Is a Significant Predictor of Apathy in Alzheimer s Disease Sergio E. Starkstein, M.D., Ph.D. Simone Brockman, M.A. David Bruce, M.D. Gustavo Petracca, M.D. Anosognosia and

More information

PREVALENCE AND CORRELATES OF ANXIETY IN ALZHEIMER S DISEASE

PREVALENCE AND CORRELATES OF ANXIETY IN ALZHEIMER S DISEASE 166 Chemerinski et al. DEPRESSION AND ANXIETY 7:166 170 (1998) PREVALENCE AND CORRELATES OF ANXIETY IN ALZHEIMER S DISEASE Erán Chemerinski, M.D., 1 * Gustavo Petracca, M.D., 1 Facundo Manes, M.D., 2 Ramón

More information

A Validation Study of Depressive Syndromes in Parkinson s Disease

A Validation Study of Depressive Syndromes in Parkinson s Disease Movement Disorders Vol. 23, No. 4, 2008, pp. 538-546 2007 Movement Disorder Society A Validation Study of Depressive Syndromes in Parkinson s Disease Sergio E. Starkstein, MD, PhD, 1,2 * Marcelo Merello,

More information

Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer s diseasepcn_

Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer s diseasepcn_ Psychiatry and Clinical Neurosciences 2012; 66: 227 234 doi:10.1111/j.1440-1819.2011.02315.x Regular Article Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer s diseasepcn_2315

More information

The nosological position of apathy in clinical practice

The nosological position of apathy in clinical practice 1 School of Psychiatry, University of Western Australia, and Department of Psychiatry, Fremantle Hospital, Fremantle, Western Australia, Australia; 2 Department of Psychiatry, Maastricht University Hospital,

More information

Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients

Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients Blackwell Science, LtdOxford, UKPCNPsychiatry and Clinical Neurosciences1323-13162005 Blackwell Publishing Pty Ltd593274279Original ArticleDementia and mild AlzheimersJ. Shimabukuro et al. Psychiatry and

More information

NEUROPSYCHOMETRIC TESTS

NEUROPSYCHOMETRIC TESTS NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract

More information

The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables

The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry 2005; 20: 531 536. Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/gps.1317 The course of neuropsychiatric

More information

A nosognosia (from the Greek nosos (illness) and

A nosognosia (from the Greek nosos (illness) and 719 PAPER A diagnostic formulation for anosognosia in S E Starkstein, R Jorge, R Mizrahi, R G Robinson... J Neurol Neurosurg Psychiatry 2006;77:719 725. doi: 10.1136/jnnp.2005.085373 See end of article

More information

The prevalence, clinical correlates and treatment of apathy in Alzheimer s disease

The prevalence, clinical correlates and treatment of apathy in Alzheimer s disease Eur. J. Psychiat. Vol. 20, N. 2, (96-106) 2006 Key words: Dementia, Alzheimer s disease, Geriatric Psychiatry, Apathy. The prevalence, clinical correlates and treatment of apathy in Alzheimer s disease

More information

9/24/2012. Amer M Burhan, MBChB, FRCP(C)

9/24/2012. Amer M Burhan, MBChB, FRCP(C) Depression and Dementia Amer M Burhan MBChB, FRCPC Head of CAMH Memory Clinic, Toronto Geriatric Neuropsychiatrist Assistant Prof Psychiatry at U of T Objectives Discuss the prevalence and impact of depression

More information

N europsychiatric symptoms can induce marked disability

N europsychiatric symptoms can induce marked disability PAPER Neuropsychiatric profiles in patients with Alzheimer s disease and vascular dementia J-L Fuh, S-J Wang, J L Cummings... See end of article for authors affiliations... Correspondence to: Dr J-L Fuh,

More information

Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer s disease and their caregivers

Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer s disease and their caregivers International Psychogeriatrics (2008), 20:2, 383 393 C 2007 International Psychogeriatric Association doi:10.1017/s1041610207006254 Printed in the United Kingdom Reliability of the Brazilian Portuguese

More information

A pathy refers to a set of behavioural, emotional, and

A pathy refers to a set of behavioural, emotional, and 579 PAPER The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson s disease P Sockeel, K Dujardin, D Devos, C Denève, A Destée, L Defebvre...

More information

Range of neuropsychiatric disturbances in patients with Parkinson s disease

Range of neuropsychiatric disturbances in patients with Parkinson s disease 492 Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital D Aarsland N G Lim C Janvin Department of Neurology, Central Hospital of Rogaland, Stavanger, Norway J P Larsen K Karlsen E Tandberg Departments

More information

CLUSTERING OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA (BPSD): A EUROPEAN ALZHEIMER S DISEASE IN CONSORTIUM (EADC) STUDY

CLUSTERING OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA (BPSD): A EUROPEAN ALZHEIMER S DISEASE IN CONSORTIUM (EADC) STUDY 426 Original articles CLUSTERING OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA (BPSD): A EUROPEAN ALZHEIMER S DISEASE IN CONSORTIUM (EADC) STUDY M. Petrovic 1,2, C. Hurt 2, D. Collins 2, A. Burns

More information

Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia

Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia 86 Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia Pai-Yi Chiu 1,3, Chung-Hsiang Liu 2, and Chon-Haw Tsai 2 Abstract- Background: Neuropsychiatric profile

More information

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge Introduction, use of imaging and current guidelines John O Brien Professor of Old Age Psychiatry University of Cambridge Why do we undertake brain imaging in AD and other dementias? Exclude other causes

More information

Marchiafava Bignami Disease (MBD) and Diffusion Tensor Image (DTI) Tractography. Priscilla Chukwueke, MD, MPH

Marchiafava Bignami Disease (MBD) and Diffusion Tensor Image (DTI) Tractography. Priscilla Chukwueke, MD, MPH Marchiafava Bignami Disease (MBD) and Diffusion Tensor Image (DTI) Tractography Priscilla Chukwueke, MD, MPH INTRODUCTION Definition: A rare CNS disease characterized by demyelination of the Corpus Callosum.

More information

Psychosis, Mood, and Personality: A Clinical Perspective

Psychosis, Mood, and Personality: A Clinical Perspective Psychosis, Mood, and Personality: A Clinical Perspective John R. Chamberlain, M.D. Assistant Director, Psychiatry and the Law Program Assistant Clinical Professor University of California San Francisco

More information

UDS Progress Report. -Standardization and Training Meeting 11/18/05, Chicago. -Data Managers Meeting 1/20/06, Chicago

UDS Progress Report. -Standardization and Training Meeting 11/18/05, Chicago. -Data Managers Meeting 1/20/06, Chicago UDS Progress Report -Standardization and Training Meeting 11/18/05, Chicago -Data Managers Meeting 1/20/06, Chicago -Training material available: Gold standard UDS informant and participant interviews

More information

THE HAMILTON Depression Rating Scale

THE HAMILTON Depression Rating Scale Reliability and Validity of the Turkish Version of the Hamilton Depression Rating Scale A. Akdemir, M.H. Türkçapar, S.D. Örsel, N. Demirergi, I. Dag, and M.H. Özbay The aim of the study was to examine

More information

The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL)

The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL) The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL Sue J. Kang, M.S., Seong Hye Choi, M.D.*, Byung H. Lee, M.A., Jay C. Kwon, M.D., Duk L. Na, M.D., Seol-Heui Han

More information

Depression among Older Adults. Prevalence & Intervention Strategies

Depression among Older Adults. Prevalence & Intervention Strategies Depression among Older Adults Prevalence & Intervention Strategies Definition Depression is a complex syndrome complex characterized by mood disturbance plus variety of cognitive, psychological, and vegetative

More information

Awareness of Deficit in Alzheimer's Disease: Relation to Caregiver Burden 1

Awareness of Deficit in Alzheimer's Disease: Relation to Caregiver Burden 1 Copyright 1997 by The Cerontological Society of America The Cerontologist Vol.37, No. 1,20-24 Patients with Alzheimer's disease (AD) show varying degrees of awareness of their deficits. To examine the

More information

Mild Cognitive Impairment (MCI)

Mild Cognitive Impairment (MCI) October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine

More information

Adrafinil: A Novel Vigilance Promoting Agent

Adrafinil: A Novel Vigilance Promoting Agent Adrafinil: A Novel Vigilance Promoting Agent Norton W. Milgram, Heather Callahan, and Christina Siwak Division of Life Sciences, University of Toronto at Scarborough, Toronto, Ontario, Canada Introduction

More information

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Measure Description Percentage of patients with dementia for whom there was a documented screening* for behavioral

More information

The place for treatments of associated neuropsychiatric and other symptoms

The place for treatments of associated neuropsychiatric and other symptoms The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public

More information

Development of a Short Version of the Apathy Evaluation Scale Specifically Adapted for Demented Nursing Home Residents

Development of a Short Version of the Apathy Evaluation Scale Specifically Adapted for Demented Nursing Home Residents Development of a Short Version of the Apathy Evaluation Scale Specifically Adapted for Demented Nursing Home Residents Ulrike Lueken, Ph.D., Ulrich Seidl, M.D., Lena Völker, Cand.Med., Elisabeth Schweiger,

More information

ANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT GURMEET SINGH 1 R. K. SHARMA 2 SUMMARY

ANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT GURMEET SINGH 1 R. K. SHARMA 2 SUMMARY Indian Journal of Psychiatry, January 29(1), pp 49-56 ANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT GURMEET SINGH 1 R. K. SHARMA 2 SUMMARY A total of 90 patients

More information

Recognizing Dementia can be Tricky

Recognizing Dementia can be Tricky Dementia Abstract Recognizing Dementia can be Tricky Dementia is characterized by multiple cognitive impairments that cause significant functional decline. Based on this brief definition, the initial expectation

More information

work was supported by the National Health and Medical Research Council of Australia

work was supported by the National Health and Medical Research Council of Australia Word Count: 2294 Apathy in older patients with type 2 diabetes David G Bruce MD 1, Melinda E Nelson BPsyche 1, Janet L Mace PhD 1, Wendy A Davis PhD 1, Timothy ME Davis DPhil 1, Sergio E Starkstein PhD

More information

DEPRESSION AFTER STROKE

DEPRESSION AFTER STROKE DEPRESSION AFTER STROKE Research study results and practical suggestions Julie Kidd 1 November 2018 Outline Definition Diagnosis Associations Prevention Treatment Outcomes From a person with stroke Emphasises

More information

Chapter 7. Depression and cognitive impairment in old age: what comes first?

Chapter 7. Depression and cognitive impairment in old age: what comes first? Chapter 7 Depression and cognitive impairment in old age: what comes first? Vinkers DJ,Gussekloo J,StekML,W estendorp RGJ,van der Mast RC. Depression and cognitive impairment in old age: what comes first?

More information

Estimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale

Estimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale Estimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale Seong Hye Choi, M.D.*, Duk L. Na, M.D., Byung Hwa Lee, M.A., Dong-Seog Hahm, M.D., Jee Hyang Jeong, M.D.,

More information

Cognitive Reserve and the Relationship Between Depressive Symptoms and Awareness of Deficits in Dementia

Cognitive Reserve and the Relationship Between Depressive Symptoms and Awareness of Deficits in Dementia Cognitive Reserve and the Relationship Between Depressive Symptoms and Awareness of Deficits in Dementia Mary Beth Spitznagel, Ph.D. Geoffrey Tremont, Ph.D. Laura B. Brown, Ph.D. John Gunstad, Ph.D. Depression

More information

Dementia. Assessing Brain Damage. Mental Status Examination

Dementia. Assessing Brain Damage. Mental Status Examination Dementia Assessing Brain Damage Mental status examination Information about current behavior and thought including orientation to reality, memory, and ability to follow instructions Neuropsychological

More information

Discussion paper Convergence and Divergence of Apathy and Depression

Discussion paper Convergence and Divergence of Apathy and Depression Discussion paper Convergence and Divergence of Apathy and Depression Abstract Apathy and depression can occur as independent constructs in various diseases, however, they have also been shown to overlap

More information

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) A. The development of multiple cognitive deficits manifested by both 1 and 2 1 1. Memory impairment 2. One (or more) of the following

More information

Alzheimer s disease dementia: a neuropsychological approach

Alzheimer s disease dementia: a neuropsychological approach Alzheimer s disease dementia: a neuropsychological approach Dr. Roberta Biundo, PhD Neuropsychology Coordinator at Parkinson s disease and movement disorders unit of San Camillo rehabilitation hospital

More information

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE 5.1 GENERAL BACKGROUND Neuropsychological assessment plays a crucial role in the assessment of cognitive decline in older age. In India, there

More information

GEPIC. An Introduction to Guide for the Evaluation of Psychiatric Impairment for Clinicians. Dr Michael Duke Senior Forensic Psychiatrist

GEPIC. An Introduction to Guide for the Evaluation of Psychiatric Impairment for Clinicians. Dr Michael Duke Senior Forensic Psychiatrist GEPIC An Introduction to Guide for the Evaluation of Psychiatric Impairment for Clinicians Dr Michael Duke Senior Forensic Psychiatrist What is psychiatric impairment? A psychiatric impairment is any loss

More information

Dementia: Advances and. Treatment

Dementia: Advances and. Treatment Chapter 2 Adding Methylphenidate to Address Apathy in Dementia- Insights from Case Reports Prem Kumar Chandrasekaran*; Stephen Thevanathan Jambunathan 1 1 Consultant Psychotherapist, The Mind Faculty,

More information

Michael Berk 1,2,3, Seetal Dodd 1, Olivia M Dean 1,3, Kristy Kohlmann 1, Lesley Berk 1,4,GinSMalhi 5,6

Michael Berk 1,2,3, Seetal Dodd 1, Olivia M Dean 1,3, Kristy Kohlmann 1, Lesley Berk 1,4,GinSMalhi 5,6 Acta Neuropsychiatrica 2010: 22: 237 242 All rights reserved DOI: 10.1111/j.1601-5215.2010.00472.x 2010 John Wiley & Sons A/S ACTA NEUROPSYCHIATRICA The validity and internal structure of the Bipolar Depression

More information

City, University of London Institutional Repository

City, University of London Institutional Repository City Research Online City, University of London Institutional Repository Citation: Hurt, C. S., Banerjee, S., Tunnard, C., Whitehead, D. L., Tsolaki, M., Mecocci, P., Kloszewska, I., Soininen, H., Vellas,

More information

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences

More information

4. Definition, clinical diagnosis and diagnostic criteria

4. Definition, clinical diagnosis and diagnostic criteria 4. Definition, clinical diagnosis and diagnostic criteria 4.1. Definition Major depression is a mood disorder consisting of a set of symptoms, which include a predominance of the affective type (pathological

More information

May He Rest in Peace

May He Rest in Peace May He Rest in Peace Neurologic Complications of AIDS Medical Knowledge Fiesta 2012 Paul K. King MD pkingmd@yahoo.com Objectives definition of HIV/AIDS what are the neurologic complications of AIDS how

More information

If you have dementia, you may have some or all of the following symptoms.

If you have dementia, you may have some or all of the following symptoms. About Dementia Dementia may be caused by a number of illnesses that affect the brain. Dementia typically leads to memory loss, inability to do everyday things, difficulty in communication, confusion, frustration,

More information

Brain imaging for the diagnosis of people with suspected dementia

Brain imaging for the diagnosis of people with suspected dementia Why do we undertake brain imaging in dementia? Brain imaging for the diagnosis of people with suspected dementia Not just because guidelines tell us to! Exclude other causes for dementia Help confirm diagnosis

More information

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease What is PRESENTS DEMENTIA? WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: Memory Reasoning Planning Learning Attention Language Perception Behavior AS OF 2013 There

More information

Clinical Characteristics of Behavioral and Psychological Symptoms in Patients with Drug-naïve Alzheimer s Disease

Clinical Characteristics of Behavioral and Psychological Symptoms in Patients with Drug-naïve Alzheimer s Disease Dementia and Neurocognitive Disorders 2012; 11: 87-94 ORIGINAL ARTICLE Clinical Characteristics of Behavioral and Psychological Symptoms in Patients with Drug-naïve Alzheimer s Disease Yong Tae Kwak, M.D.,

More information

Gerardo Machnicki 1, Ricardo F. Allegri 1,2 *, Carol Dillon 1, Cecilia M. Serrano 1,2 and Fernando E Taragano 2 SUMMARY INTRODUCTION

Gerardo Machnicki 1, Ricardo F. Allegri 1,2 *, Carol Dillon 1, Cecilia M. Serrano 1,2 and Fernando E Taragano 2 SUMMARY INTRODUCTION INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry (2008) Published online in Wiley InterScience (www.interscience.wiley.com).2133 Cognitive, functional and behavioral factors associated

More information

fine age at onset? And, once defined, how consistent is this clinical measure? Despite considerable research

fine age at onset? And, once defined, how consistent is this clinical measure? Despite considerable research Clinical Characterization of Alzheimer s Disease: Reliability of Age at Onset and a New Descriptor, Age at Shift Gary W. Small, MD; David E. Kuhl, MD; Denson G. Fujikawa, MD; J. Wesson Ashford, MD, PhD

More information

Neuropsychiatric consequences of traumatic brain injury. Causes of head injury. Physical symptoms. Outcome (Thornhill et al, 2001)

Neuropsychiatric consequences of traumatic brain injury. Causes of head injury. Physical symptoms. Outcome (Thornhill et al, 2001) Neuropsychiatric consequences of traumatic brain injury Professor Shoumitro Deb, MD. University of Birmingham & Warwick Medical School, UK. Causes of head injury Fall Assault RTA Deb et al (1999) 42% 27%

More information

The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature

The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature Review article: The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature Dr. Ivan Netto 1, Aditya Iyer 2, Dr. Prathamesh

More information

INSTRUCTION MANUAL Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures

INSTRUCTION MANUAL Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures PHQ and GAD-7 Instructions P. 1/9 INSTRUCTION MANUAL Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures TOPIC PAGES Background 1 Coding and Scoring 2, 4, 5 Versions 3 Use as Severity

More information

DSM-5 MAJOR AND MILD NEUROCOGNITIVE DISORDERS (PAGE 602)

DSM-5 MAJOR AND MILD NEUROCOGNITIVE DISORDERS (PAGE 602) SUPPLEMENT 2 RELEVANT EXTRACTS FROM DSM-5 The following summarizes the neurocognitive disorders in DSM-5. For the complete DSM-5 see Diagnostic and Statistical Manualof Mental Disorders, 5th edn. 2013,

More information

Key words: Huntington s disease, apathy, cognition, depression, companion, self-rated,

Key words: Huntington s disease, apathy, cognition, depression, companion, self-rated, Rating apathy in Huntington s disease: Patients and companions agree. Sarah Mason PhD* 1, Roger A Barker MBBS MRCP PhD 1, 2 1 John Van Geest Centre for Brain Repair, University of Cambridge, UK 2 Department

More information

HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D.

HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D. HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D. Professor of Psychiatry, Neurology, and Pediatrics University of Iowa, Iowa City, Iowa The information provided

More information

Words: 1393 (excluding table and references) Exploring the structural relationship between interviewer and self-rated affective

Words: 1393 (excluding table and references) Exploring the structural relationship between interviewer and self-rated affective Interviewer and self-rated affective symptoms in HD 1 Words: 1393 (excluding table and references) Tables: 1 Corresponding author: Email: Maria.Dale@leicspart.nhs.uk Tel: +44 (0) 116 295 3098 Exploring

More information

Dementia Diagnosis Guidelines Primary Care

Dementia Diagnosis Guidelines Primary Care Dementia Diagnosis Guidelines Primary Care Dementia Diagnosis Primary Care Guidelines Introduction Dementia is a long term condition, which primarily affects people over the age of 65 (late on-set dementia)

More information

The Effect of Pramipexole on Depressive Symptoms in Parkinson's Disease.

The Effect of Pramipexole on Depressive Symptoms in Parkinson's Disease. Kobe J. Med. Sci., Vol. 56, No. 5, pp. E214-E219, 2010 The Effect of Pramipexole on Depressive Symptoms in Parkinson's Disease. NAOKO YASUI 1, KENJI SEKIGUCHI 1, HIROTOSHI HAMAGUCHI 1, and FUMIO KANDA

More information

Running head: DEPRESSIVE DISORDERS 1

Running head: DEPRESSIVE DISORDERS 1 Running head: DEPRESSIVE DISORDERS 1 Depressive Disorders: DSM-5 Name: Institution: DEPRESSIVE DISORDERS 2 Abstract The 2013 update to DSM-5 saw revisions of the psychiatric nomenclature, diagnostic criteria,

More information

Positron Emission Tomography Metabolic Correlates of Apathy in Alzheimer Disease

Positron Emission Tomography Metabolic Correlates of Apathy in Alzheimer Disease ORIGINAL CONTRIBUTION Positron Emission Tomography Metabolic Correlates of Apathy in Alzheimer Disease Gad A. Marshall, MD; Lorena Monserratt, MA; Dylan Harwood, PhD; Mark Mandelkern, MD, PhD; Jeffrey

More information

Buy full version here - for $ 7.00

Buy full version here - for $ 7.00 This is a Sample version of the Apathy Evaluation Scale (AES) The full version of watermark.. the AES comes without sample The full complete 40 page version includes AES Overview information AES Scoring/

More information

A randomized controlled clinical trial of Citalopram versus Fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD)

A randomized controlled clinical trial of Citalopram versus Fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD) Eur Child Adolesc Psychiatry (2009) 18:131 135 DOI 10.1007/s00787-007-0634-z ORIGINAL CONTRIBUTION Javad Alaghband-Rad Mitra Hakimshooshtary A randomized controlled clinical trial of Citalopram versus

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Atri A, Frölich L, Ballard C, et al. Effect of idalopirdine as adjunct to cholinesterase inhibitors on in cognition in patients with Alzheimer disease: three randomized clinical

More information

The Pleasant Events Schedule-AD: Psychometric Properties and Relationship to Depression and Cognition in Alzheimer's Disease Patients 1

The Pleasant Events Schedule-AD: Psychometric Properties and Relationship to Depression and Cognition in Alzheimer's Disease Patients 1 Copyright 1997 by The Cerontological Society of America The Cerontologist Vol.37, No. 1,40-45 The Pleasant Events Schedule-AD (PES-AD) has been described as a useful tool for identifying pleasant activities

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a preprint version which may differ from the publisher's version. For additional information about this

More information

The Neurology of HIV Infection. Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University

The Neurology of HIV Infection. Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University The Neurology of HIV Infection Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University HIV/AIDS Epidemiology World-wide pandemic, 40 million affected U.S.- Disproportionate

More information

Primary Care: Referring to Psychiatry

Primary Care: Referring to Psychiatry Primary Care: Referring to Psychiatry Carol Capitano, PhD, APRN-BC Assistant Professor, Clinical Educator University of New Mexico College of Nursing University of New Mexico Psychiatric Center Objectives

More information

Number of Items. Response Categories. Part V: Specific Behavior Scales-Sleep Scales. Based on past month

Number of Items. Response Categories. Part V: Specific Behavior Scales-Sleep Scales. Based on past month Part V: Specific Behavior Scales-Sleep Scales Based on past month First 4 items ask for time or amount of sleep 41. Pittsburgh Sleep Quality Index (PSQI) Sleep quality Sleep latency Sleep duration Habitual

More information

UNC CFAR Social and Behavioral Science Research Core SABI Database

UNC CFAR Social and Behavioral Science Research Core SABI Database INSTRUMENT TITLE: Hamilton Depression Rating Scale (HDRS) SOURCE ARTICLE: Hamilton, M. (1960). A Rating Scale for Depression. J Neurol Neurosurg Psychiatry, 23: 56-62. RESPONSE OPTIONS: The variables are

More information

Parkinsonian Disorders with Dementia

Parkinsonian Disorders with Dementia Parkinsonian Disorders with Dementia George Tadros Consultant in Old Age Liaison Psychiatry, RAID, Heartlands Hospital Professor of Dementia and Liaison Psychiatry, Aston Medical School Aston University

More information

Dementia is a common neuropsychiatric disorder characterized by progressive impairment of

Dementia is a common neuropsychiatric disorder characterized by progressive impairment of Focused Issue of This Month Diagnosis and Treatment for Behavioral and Psychological Symptoms of Dementia Byoung Hoon Oh, MD Department of Psychiatry, Yonsei University College of Medicine E - mail : drobh@yuhs.ac

More information

Depressive Disorder in Children and Adolescents: Dysthymic Disorder and the Use of Self-Rating Scales in Assessment

Depressive Disorder in Children and Adolescents: Dysthymic Disorder and the Use of Self-Rating Scales in Assessment Depressive Disorder in Children and Adolescents: Dysthymic Disorder and the Use of Self-Rating Scales in Assessment Stuart Fine, MB, FRCP (C), Marlene Moretti, MA, Glenn Haley, MA, Simon Fraser University.

More information

Treatment of AD with Stabilized Oral NADH: Preliminary Findings

Treatment of AD with Stabilized Oral NADH: Preliminary Findings MS # 200 000 128 Treatment of AD with Stabilized Oral NADH: Preliminary Findings G.G. Kay, PhD, V. N. Starbuck, PhD and S. L. Cohan, MD, PhD Department of Neurology, Georgetown University School of Medicine

More information

Neuroimaging for dementia diagnosis. Guidance from the London Dementia Clinical Network

Neuroimaging for dementia diagnosis. Guidance from the London Dementia Clinical Network Neuroimaging for dementia diagnosis Guidance from the London Dementia Clinical Network Authors Dr Stephen Orleans-Foli Consultant Psychiatrist, West London Mental Health NHS Trust Dr Jeremy Isaacs Consultant

More information

depression and anxiety in later life clinical challenges and creative research

depression and anxiety in later life clinical challenges and creative research 2 nd Annual MARC Symposium Critical Themes in Ageing Melbourne, 10 th August 2018 depression and anxiety in later life clinical challenges and creative research Nicola T Lautenschlager, MD, FRANZCP Professor

More information

Buy full version here - for $ 5.00

Buy full version here - for $ 5.00 This is a Sample version of the Apathy Inventory (AI) The full version of watermark.. the AI comes without sample The full complete 13 page version includes AI Overview information AI Scoring/ Administration

More information

AMPS : A Quick, Effective Approach To The Primary Care Psychiatric Interview

AMPS : A Quick, Effective Approach To The Primary Care Psychiatric Interview AMPS : A Quick, Effective Approach To The Primary Care Psychiatric Interview February 7, 2012 Robert McCarron, D.O. Assosicate Clinical Professor Internal Medicine / Psychiatry / Pain Medicine UC Davis,

More information

A prospective study of dementia with Lewy bodies

A prospective study of dementia with Lewy bodies Age and Ageing 998; 27: 6-66 998, British Geriatrics Society A prospective study of dementia with Lewy bodies CLIVE G. BALLARD, JOHN O'BRIEN, KATH LOWERX GARETH A. AYRE, RICHARD HARRISON, ROBERT PERRY,

More information

Clinical Study Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer s and Cognitively Normal Elderly

Clinical Study Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer s and Cognitively Normal Elderly Hindawi Publishing Corporation Depression Research and Treatment Volume 2011, Article ID 396958, 6 pages doi:10.1155/2011/396958 Clinical Study Depressive Symptom Clusters and Neuropsychological Performance

More information

Behavioural disturbances in dementia patients and quality of the marital relationship

Behavioural disturbances in dementia patients and quality of the marital relationship INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry 2003; 18: 149 154. Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/gps.807 Behavioural disturbances

More information

Downloaded from irje.tums.ac.ir at 9:18 IRDT on Saturday September 15th 2018

Downloaded from irje.tums.ac.ir at 9:18 IRDT on Saturday September 15th 2018 .5159 :2 7 1390 : 88989123 4 3 2 1 1 : 2 3 4. :. :. 84 : Burden Iranian Version of Caregiver.. Neuropsychiatric Inventory ().. 85. 2/4 39/3 : ebrahemen@gmail.com : 89/10/4 : 89/8/26: :. : 40 (116 58).

More information

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient DEMENTIA WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient Progressive and disabling Not an inherent aspect of

More information

Baseline Characteristics of Patients Attending the Memory Clinic Serving the South Shore of Boston

Baseline Characteristics of Patients Attending the   Memory Clinic Serving the South Shore of Boston Article ID: ISSN 2046-1690 Baseline Characteristics of Patients Attending the www.thealzcenter.org Memory Clinic Serving the South Shore of Boston Corresponding Author: Dr. Anil K Nair, Chief of Neurology,

More information

Mild cognitive impairment A view on grey areas of a grey area diagnosis

Mild cognitive impairment A view on grey areas of a grey area diagnosis Mild cognitive impairment A view on grey areas of a grey area diagnosis Dr Sergi Costafreda Senior Lecturer Division of Psychiatry, UCL Islington Memory Service, C&I NHS FT s.costafreda@ucl.ac.uk London

More information

Cognitive Symptoms of Schizophrenia

Cognitive Symptoms of Schizophrenia Cognitive Symptoms of Schizophrenia In other information sheets we have discussed the two major types of symptoms traditionally thought to characterise schizophrenia: first of all the positive symptoms

More information

Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT

Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms State of the art lecture March 4-2012 Philippe H Robert, Philippe Nice - France Robert The diagnosis of AD Neuropsychiatric

More information

Behavioral Interventions

Behavioral Interventions Behavioral Interventions Linda K. Shumaker, R.N.-BC, MA Pennsylvania Behavioral Health and Aging Coalition Behavioral Management is the key in taking care of anyone with a Dementia! Mental Health Issues

More information

Introduction to Dementia: Complications

Introduction to Dementia: Complications Introduction to Dementia: Complications Created in March 2005 Duration: about 15 minutes Axel Juan, MD The Geriatrics Institute axel.juan@med.va.gov 305-575-3388 Credits Principal medical contributor:

More information

cognitive decline, and physical impairments in patients with Parkinson's disease

cognitive decline, and physical impairments in patients with Parkinson's disease Journal of Neurology, Neurosurgery, and Psychiatry 1992;55:377-382 Johns Hopkins School of Medicine, Baltimore, MD21205 Department of Pscyhiatry and Behavioural Sciences Sergio E Starkstein Robert G Robinson

More information

Neuropsychiatric Syndromes

Neuropsychiatric Syndromes Neuropsychiatric Syndromes Susan Czapiewski,MD VAHCS December 10, 2015 Dr. Czapiewski has indicated no potential conflict of interest to this presentation. She does intend to discuss the off-label use

More information

Neuropsychiatric Symptoms and Syndromes in a Large Cohort of Newly Diagnosed, Untreated Patients With Alzheimer Disease

Neuropsychiatric Symptoms and Syndromes in a Large Cohort of Newly Diagnosed, Untreated Patients With Alzheimer Disease Neuropsychiatric Symptoms and Syndromes in a Large Cohort of Newly Diagnosed, Untreated Patients With Alzheimer Disease Gianfranco Spalletta, M.D., Ph.D., Massimo Musicco, M.D., Alesandro Padovani, M.D.,

More information

Mild Cognitive Impairment

Mild Cognitive Impairment Mild Cognitive Impairment Victor W. Henderson, MD, MS Departments of Health Research & Policy (Epidemiology) and of Neurology & Neurological Sciences Stanford University Director, Stanford Alzheimer s

More information

. Neuropsychiatric Inventory (NPI) :

. Neuropsychiatric Inventory (NPI) : Downloaded Downloaded from http://journals.tums.ac.ir/ from irje.tums.ac.ir at 9:18 on IRDT Monday, Saturday February September 27, 2012 15th 2018.5159 :2 7 1390 : 88989123 4 3 2 1 1 : 2 3 4. :. :. 84

More information

Measuring health-related quality of life in persons with dementia DOMS results & recommendations

Measuring health-related quality of life in persons with dementia DOMS results & recommendations Measuring health-related quality of life in persons with dementia DOMS results & recommendations Madeleine King, Siggi Zapart, Jan Sansoni, Nick Marosszeky On behalf of the Dementia Outcomes Measurement

More information